FRA:22UA - Deutsche Boerse Ag - US09075V1026 - ADR - Currency: EUR
We assign a fundamental rating of 3 out of 10 to 22UA. 22UA was compared to 71 industry peers in the Biotechnology industry. 22UA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 22UA is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.95% | ||
ROE | -3.43% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 84.9% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Altman-Z | 6.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 7.45 | ||
Quick Ratio | 7.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
FRA:22UA (4/25/2025, 7:00:00 PM)
102.1
-0.1 (-0.1%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 8.92 | ||
P/FCF | N/A | ||
P/OCF | 118.17 | ||
P/B | 1.26 | ||
P/tB | 1.35 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.95% | ||
ROE | -3.43% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 84.9% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 151.78% | ||
Cap/Sales | 16.44% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 7.45 | ||
Quick Ratio | 7.34 | ||
Altman-Z | 6.73 |